Xeris Biopharma Holdings Inc (NASDAQ:XERS) shares, rose in value on Wednesday, March 26, with the stock price down by -2.73% to the previous day’s close as strong demand from buyers drove the stock to $5.71.
Actively observing the price movement in the last trading, the stock closed the session at $5.87, falling within a range of $5.64 and $6.0672. The value of beta (5-year monthly) was 1.208. Referring to stock’s 52-week performance, its high was $5.97, and the low was $1.69. On the whole, XERS has fluctuated by 56.01% over the past month.
With the market capitalization of Xeris Biopharma Holdings Inc currently standing at about $879.00 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-05.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 262.3M, with a low estimate of 56.29M and a high estimate of 59.2M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 57.61M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that XERS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of XERS currently trading nearly 20.78% and 41.69% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 76.87, while the 7-day volatility ratio is showing 6.15% which for the 30-day chart, stands at 6.80%. Furthermore, Xeris Biopharma Holdings Inc (XERS)’s beta value is 1.16, and its average true range (ATR) is 0.30.
A comparison of Xeris Biopharma Holdings Inc (XERS) with its peers suggests the former has fared considerably weaker in the market. XERS showed an intraday change of -2.73% in last session, and over the past year, it grew by 171.90%%.
Data on historical trading for Xeris Biopharma Holdings Inc (NASDAQ:XERS) indicates that the trading volumes over the past 10 days have averaged 4.38 and over the past 3 months, they’ve averaged 2.40 million. According to company’s latest data on outstanding shares, there are 149.43 million shares outstanding.
Nearly 7.76% of Xeris Biopharma Holdings Inc’s shares belong to company insiders and institutional investors own 42.76% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.21 million shares as on 2025-03-14, resulting in a short ratio of 3.4. According to the data, the short interest in Xeris Biopharma Holdings Inc (XERS) stood at 746.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 10.27 million. The stock has risen by 68.44% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the XERS stock heading into the next quarter.
